Leuprolide Withdrawn Phase 3 Trials for Uterine Leiomyomas Treatment

IndicationsStatusPurposePhase
WithdrawnTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT02736435Treatment of Uterine Fibroids With Magnetic Resonance Guided High Intensity Focused Ultrasound